MSc. Eva Müller
Professional Experience
PhD CandidateInstitute for the Research on HIV and AIDS-associated Diseases |
Oct 2022-presentEssen, Germany |
Guest Scientist |
May 2022-Sep 2022Berlin, Germany |
Master's studentInstitute for the Research on HIV and AIDS-associated Diseases |
Sep 2021-March 2022Berlin, Germany |
Student Assistant |
Sep 2020-Sep 2021Berlin, Germany |
Student Assistant |
Oct 2018-April 2020Berlin, Germany |
Bachelor Student |
March 2018-Nov 2019Berlin, Germany |
Education and Degrees
Master of Science in Biophyscis |
Oct 2015-July 2018Berlin, Germany |
Bachelor of Science in Biophysics |
Oct 2011-July2015Berlin, Germany |
Publications
- A Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6 trans-Signaling and Cellular Infection with SARS-CoV-2. Julia Ettich, Julia Werner, Hendrik T. Weitz, Eva Müller, Roland Schwarzer, Philipp A. Lang, Jürgen Scheller, Jens M. Moll, Journal of Virology 2022 Feb 23;96(4):e0162221, DOI:10.1128/JVI.01622-21. LINK
- Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus, Lutz Adam, Eva Müller, Kai Ludwig, Simon Klenk, Daniel Lauster, Susanne Liese, Andreas Herrmann, and Christian P. R. Hackenberger, Bioconjugate Chemistry 2022 33 (7), 1269-1278, DOI: 10.1021/acs.bioconjchem.2c00166. LINK